Skip to main content
Search results
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-ramucirumab-plus-erlotinib-first-line-metastatic-nsclc
8 months ago -
FDA approves ramucirumab plus erlotinib for first-line metastatic NSCLC On May...and Company) in combination with erlotinib for first-line treatment ...
https://www.fda.gov/medical-devices/in-vitro-diagnostics/list-cleared-or-approved-companion-diagnostic-devices-in-vitro-and-imaging-tools
about 2 months ago -
Cancer (NSCLC) - Tissue Tarceva (erlotinib) NDA 021743 EGFR (HER1) Exon 19 deletion...(NSCLC) - Tissue or Plasma Tarceva (erlotinib) NDA 021743 EGFR ...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-osimertinib-first-line-treatment-metastatic-nsclc-most-common-egfr-mutations
8 months ago -
...treatment of gefitinib 250 mg or erlotinib 150 mg orally once daily. Of those
https://www.fda.gov/drugs/fdas-adverse-event-reporting-system-faers/october-december-2023-potential-signals-serious-risksnew-safety-information-identified-fda-adverse
12 months ago -
...(afatinib) Iressa (gefitinib) Tarceva (erlotinib) Cardiac failure FDA is evaluating
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-osimertinib-non-small-cell-lung-cancer
8 months ago -
...tyrosine kinase inhibitors, such as erlotinib, gefitinib, and afatinib. Unfortunately
https://www.fda.gov/media/169235/download
over 2 years ago -
Doxorubicin HCl Liposomal Injection • Erlotinib Tablets • Imatinib Tablets • Leuprolide
https://www.fda.gov/about-fda/science-research-nctr/meagan-myers
3 months ago -
...-2_23. Springer US. Outgrowth of Erlotinib-Resistant Subpopulations Recapitulated
https://www.fda.gov/drugs/fdas-adverse-event-reporting-system-faers/july-september-2022-potential-signals-serious-risksnew-safety-information-identified-fda-adverse
over 2 years ago -
...(afatinib) Iressa (gefitinib) Tarceva (erlotinib) Tagrisso (osimertinib) Vizimpro
https://www.fda.gov/media/178811/download
almost 3 years ago -
Interval Prolongation: severe Erlotinib ERLOTINIB ERLOTINIB NA sp ambiguous myocardial...infarct/tachycardia severe ERLOTINIB HYDROCHLORIDE ERLOTINIB ...
https://www.fda.gov/media/169915/download
almost 2 years ago -
Randomized, Double-Blind Trial of Erlotinib in Inhibiting EGF Receptor Signaling...“Molecular Cancer Prevention of IPMNs with Erlotinib.” (Session ...
https://www.fda.gov/media/71502/download
8 days ago -
ENTACAPONE, ENTACAPONE ERLOTINIB HYDROCHLORIDE, ERLOTINIB HYDROCHLORIDE ERYTHROMYCIN...ERGOCALCIFEROL, ERGOCALCIFEROL ERLOTINIB HYDROCHLORIDE, ERLOTIN ...
https://www.fda.gov/about-fda/science-research-nctr/barbara-parsons
about 1 month ago -
...2020, 61(1):152-175. Outgrowth of Erlotinib-Resistant Subpopulations Recapitulated
https://www.fda.gov/media/92325/download
almost 10 years ago -
N21-743S021 Erlotinib Clinpharm BPCA...N21-743S021 Erlotinib Clinpharm BPCA Clinical Pharmacology NDA Review NDA/Supplement...Standard Brand Name ...
https://www.fda.gov/media/91314/download
about 10 years ago -
N021743 Erlotinib Amendment...N021743 Erlotinib Amendment DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and...for pediatric studies for Tarceva (erloti ...
https://www.fda.gov/media/176639/download
about 1 year ago -
Neck Cancer 2012 Phase II Study of Erlotinib Plus Radiation Therapy in Patients...Craniofacial Research (NIDCR) 5. Erlotinib in Patients with ...
https://www.fda.gov/media/103879/download
8 days ago -
...2010RX RLD: N003444 ERLOTINIB HYDROCHLORIDE TABLET;ORAL ERLOTINIB HYDROCHLORIDE ZYDUS
https://www.fda.gov/media/91313/download
about 10 years ago -
N021743 Erlotinib Original Written Request...N021743 Erlotinib Original Written Request DEPARTMENT OF HEALTH & HUMAN SERVICES...Requests for erlotinib ...
https://www.fda.gov/media/92313/download
almost 10 years ago -
N21-743S021 Erlotinib Clinical BPCA...N21-743S021 Erlotinib Clinical BPCA CLINICAL REVIEW Application Type Application...Suzanne Demko, PA-C (TL) ...
https://www.fda.gov/drugs/development-resources/list-determinations-including-written-request
about 1 month ago -
...198 KB] Amendment 3 [PDF - 230 KB] Erlotinib OSI Pharmaceuticals 3/18/2015 Written
https://www.fda.gov/media/181484/download
8 months ago -
Brittain K. Hope in a Bottle for NSCLC: Erlotinib. Palmetto Pharmacist. Volume 55 –
